CoverageForm 410-K10-Q8-K13D13G13F

ACHV Achieve Life Sciences, Inc. - 8-K

Filed Mar 24, 2026. See issuer overview · financials · original on SEC.gov ↗
Accession
0001193125-26-120687
2.029.01

Item 2.02 - Results of Operations and Financial Condition

Earnings press release item. The actual results are typically in Exhibit 99.1 - fetch may not have completed.

Item 2.02 Results of Operations and Financial Condition.

On March 24, 2026, Achieve Life Sciences, Inc. issued a press release announcing its financial results for the fourth quarter and year ended December 31, 2025. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

Item 9.01 - Financial Statements and Exhibits

112 words

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

Exhibit No.

Description

99.1

104

Press release of Achieve Life Sciences, Inc. dated March 24, 2026

Cover Page Interactive Data File (embedded within the Inline XBRL document)

________________________

The information in Item 2.02 of this Form 8-K and Exhibit 99.1 attached hereto is furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

________________________